Sensorimotor Cortex Gamma-Aminobutyric Acid Concentration Correlates with Impaired Performance in Patients with MS

REFERENCES

1. 1.↵
   1. Chang L,
   2. Cloak CC,
   3. Ernst T

   . Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry 2003;64(suppl 3):7–14
2. 2.↵
   1. Bütefisch CM,
   2. Davis BC,
   3. Wise SP,
   4. et al

   . Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci U S A 2000;97:3661–65

   Abstract/FREE Full Text
3. 3.↵
   1. Castro-Alamancos MA,
   2. Connors BW

   . Short-term synaptic enhancement and long-term potentiation in neocortex. Proc Natl Acad Sci U S A 1996;93:1335–39

   Abstract/FREE Full Text
4. 4.↵
   1. Castro-Alamancos MA,
   2. Donoghue JP,
   3. Connors BW

   . Different forms of synaptic plasticity in somatosensory and motor areas of the neocortex. J Neurosci 1995;15:5324–33

   Abstract
5. 5.↵
   1. Floyer-Lea A,
   2. Wylezinska M,
   3. Kincses T,
   4. et al

   . Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J Neurophysiol 2006;95:1639–44

   Abstract/FREE Full Text
6. 6.↵
   1. Levy LM,
   2. Hallett M

   . Impaired brain GABA in focal dystonia. Ann Neurol 2002;51:93–101

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Levy LM,
   2. Ziemann U,
   3. Chen R,
   4. et al

   . Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol 2002;52:755–61

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Pleger B,
   2. Schwenkreis P,
   3. Dinse HR,
   4. et al

   . Pharmacological suppression of plastic changes in human primary somatosensory cortex after motor learning. Exp Brain Res 2003;148:525–32

   PubMedWeb of Science
9. 9.↵
   1. Stagg CJ,
   2. Bachtiar V,
   3. Johansen-Berg H

   . The role of GABA in human motor learning. Curr Biol 2011;21:480–84

   CrossRefPubMed
10. 10.↵
    1. Reddy H,
    2. Narayanan S,
    3. Arnoutelis R,
    4. et al

    . Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 2000;123(pt 11):2314–20

    Abstract/FREE Full Text
11. 11.↵
    1. Sailer M,
    2. Fischl B,
    3. Salat D,
    4. et al

    . Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003;126(pt 8):1734–44

    Abstract/FREE Full Text
12. 12.↵
    1. Rocca MA,
    2. Mezzapesa DM,
    3. Falini A,
    4. et al

    . Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2003;18:847–55

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Reddy H,
    2. Narayanan S,
    3. Woolrich M,
    4. et al

    . Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain 2002;125(pt 12):2646–57

    Abstract/FREE Full Text
14. 14.↵
    1. Rocca MA,
    2. Falini A,
    3. Colombo B,
    4. et al

    . Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 2002;51:330–39

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Cutter GR,
    2. Baier ML,
    3. Rudick RA,
    4. et al

    . Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122(pt 5):871–82

    Abstract/FREE Full Text
16. 16.↵
    1. Bhattacharyya PK,
    2. Beall EB,
    3. Lowe MJ

    . Residual water for motion identification in J-difference editing. In: Proceedings of the International Society for Magnetic Resonance Workshop on Current Concepts of Motion Correction for MRI and MRS, Kitzbühel, Tyrol, Austria. February 24–28, 2010
17. 17.↵
    1. Bhattacharyya PK,
    2. Lowe MJ,
    3. Phillips MD

    . Spectral quality control in motion-corrupted single-voxel J-difference editing scans: an interleaved navigator approach. Magn Reson Med 2007;58:808–12

    CrossRefPubMed
18. 18.↵
    1. Vanhamme L,
    2. van den Boogaart A,
    3. Van Huffel S

    . Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35–43

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Mathiowetz V,
    2. Volland G,
    3. Kashman N,
    4. et al

    . Adult norms for the Box and Block Test of manual dexterity. Am J Occup Ther 1985;39:386–91

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Gronwall DM

    . Paced Auditory Serial-Addition Task: a measure of recovery from concussion. Percept Mot Skills 1977;44:367–73

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Rudick R,
    2. Antel J,
    3. Confavreux C,
    4. et al

    . Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997;42:379–82

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Fischer JS,
    2. Rudick RA,
    3. Cutter GR,
    4. et al

    . The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment—National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999;5:244–50

    Abstract/FREE Full Text
23. 23.↵
    1. Mescher M,
    2. Merkle H,
    3. Kirsch J,
    4. et al

    . Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998;11:266–72

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Bhattacharyya PK,
    2. Phillips MD,
    3. Stone LA,
    4. et al

    . In vivo magnetic resonance spectroscopy measurement of gray-matter and white-matter gamma-aminobutyric acid concentration in sensorimotor cortex using a motion-controlled MEGA point-resolved spectroscopy sequence. Magn Reson Imaging 2011;29:374–79

    CrossRefPubMed
25. 25.↵
    1. Henry PG,
    2. Dautry C,
    3. Hantraye P,
    4. et al

    . Brain GABA editing without macromolecule contamination. Magn Reson Med 2001;45:517–20

    CrossRefPubMed
26. 26.↵
    1. Terpstra M,
    2. Ugurbil K,
    3. Gruetter R

    . Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magn Reson Med 2002;47:1009–12

    CrossRefPubMed
27. 27.↵
    1. Naressi A,
    2. Couturier C,
    3. Devos JM,
    4. et al

    . Java-based graphical user interface for the MRUI quantitation package. Magma 2001;12:141–52

    CrossRefPubMed
28. 28.↵
    1. Pijnappel WW,
    2. van den Boogaart A,
    3. de Beer R,
    4. et al

    . SVD-based quantification of magnetic resonance signals. J Magn Reson 1992;97:122–34

    CrossRefWeb of Science
29. 29.↵
    1. Zhang Y,
    2. Brady M,
    3. Smith S

    . Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW,
    4. et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–19

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Mlynárik V,
    2. Gruber S,
    3. Moser E

    . Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed 2001;14:325–31

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Bhattacharyya PK

    . Systematic error in the measurement of [GABA]/[Cr] ratio using methyl resonance of creatine. In: Proceedings of the International Society for Magnetic Resonance in Medicine Workshop on MR Spectroscopy and Neurotransmitter Function in Neuropsychiatric Disorders, Quebec City, Quebec, Canada. November 7–10, 2008
33. 33.↵
    1. Gasparovic C,
    2. Song T,
    3. Devier D,
    4. et al

    . Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 2006;55:1219–26

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Laule C,
    2. Vavasour IM,
    3. Moore GR,
    4. et al

    . Water content and myelin water fraction in multiple sclerosis: a T2 relaxation study. J Neurol 2004;251:284–93

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Cox RW,
    2. Hyde JS

    . Software tools for analysis and visualization of fMRI data. NMR Biomed 1997;10:171–78

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Lowe MJ,
    2. Russell DP

    . Treatment of baseline drifts in fMRI time series analysis. J Comput Assist Tomogr 1999;23:463–73

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Talairach J,
    2. Tournoux P

    . Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical; 1988
38. 38.↵
    1. Mayka MA,
    2. Corcos DM,
    3. Leurgans SE,
    4. et al

    . Three-dimensional locations and boundaries of motor and premotor cortices as defined by functional brain imaging: a meta-analysis. Neuroimage 2006;31:1453–74

    CrossRefPubMedWeb of Science
39. 39.↵
    1. McDonough J,
    2. Dutta R,
    3. Gudz T,
    4. et al

    . Decreases in GABA and mitochondrial genes are implicated in MS cortical pathology through microarray analysis of postmortem MS cortex. Soc Neurosci Abstr 2003;213:212
40. 40.↵
    1. Dutta R,
    2. McDonough J,
    3. Yin X,
    4. et al

    . Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006;59:478–89

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Ziemann U,
    2. Muellbacher W,
    3. Hallett M,
    4. et al

    . Modulation of practice-dependent plasticity in human motor cortex. Brain 2001;124:1171–81

    Abstract/FREE Full Text
42. 42.↵
    1. Horenstein C,
    2. Lowe MJ,
    3. Koenig KA,
    4. et al

    . Comparison of unilateral and bilateral complex finger tapping-related activation in premotor and primary motor cortex. Hum Brain Mapp 2009;30:1397–412

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Lowe MJ,
    2. Beall EB,
    3. Sakaie KE,
    4. et al

    . Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity. Hum Brain Mapp 2008;29:818–27

    CrossRefPubMedWeb of Science
44. 44.↵
    1. Epperson CN,
    2. Haga K,
    3. Mason GF,
    4. et al

    . Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2002;59:851–58

    CrossRefPubMedWeb of Science